ReviewCancers2021

Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions.

Rita T Lawlor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.